Improving the treatment of Parkinson's disease: Structure-based development of novel 5-HT2A receptor antagonists/inverse agonists.
Ma M, Yang Y, Du G, Dai Y, Zhu X, Wang W, Xu H, Zhang J, Zheng L, Zou F, Yang H, Liu B, Liu W, Ye L, Zhang R, Tian J.
Ma M, et al. Among authors: liu b, liu w.
Eur J Med Chem. 2022 Apr 15;234:114246. doi: 10.1016/j.ejmech.2022.114246. Epub 2022 Mar 2.
Eur J Med Chem. 2022.
PMID: 35279606